Financial News

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

AbbVie (NY: ABBV )

200.47 -3.08 (-1.51%)
Official Closing Price Updated: 4:10 PM EST, Nov 4, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about AbbVie

< Previous 1 2
...
23 24 25 26 27 28 29 30 31
...
69 70 Next >
Dow Jones Leads Weekly Gains As Tesla, Netflix Sell-Offs Dent Nasdaq; Big Banks Show Resilience To Volatility
Via Benzinga
3 High-Yield Dividend Stocks I Plan on Holding Forever
These stocks offer great yields but have even better underlying businesses. 
Via The Motley Fool
3 of the Best Dividend Stocks to Buy for Passive Income Growth
For investors looking to create a meaningful stream of passive income in retirement, these dividends stocks are great options. 
Via InvestorPlace
Check Out What Whales Are Doing With ABBV
Via Benzinga
Here's How Much You Would Have Made Owning AbbVie Stock In The Last 10 Years
Via Benzinga
Peering Into AbbVie's Recent Short Interest
Via Benzinga
AbbVie Inc. (NYSE: ABBV) Highlighted for Surprising Price Action
Via Investor Brand Network
7 Fantastic Forever Stocks for Long-Term Lucrative Gains
These forever stocks to buy offer compelling bull cases for the long-haul, alongside spectacular upside potential. 
Via InvestorPlace
Top Yielding Dividend Aristocrats
Here are some of the top Dividend Aristocrats in 2023. 
Via Talk Markets
3 Biotech Stocks for Getting Rich in 2023
These 3 biotech stocks have seen stable or growing revenue this year. This makes them companies to keep on your watchlist. 
Via InvestorPlace
BeiGene's Brukinsa Positioned as Preferred BTK Inhibitor: Analyst Says Survey Supports Bullish View
Citi initiated coverage on BeiGene Ltd (NASDAQ: BGNE) with a price target of $275 and a B 
Via Benzinga
MoonLake's Potential Sale: Stock Price Up Fivefold Since Public Debut In 2022
MoonLake Immunotherapeutics (NASDAQ: MLTX) has reportedly engaged an investment bank as the Swiss company looks for a potential sale. The company focuses on developing antibody-derived treatments for... 
Via Benzinga
Analyst Ratings for AbbVie
Via Benzinga
AbbVie Unusual Options Activity For July 12
Via Benzinga
Check Out What Whales Are Doing With ABBV
Via Benzinga
Is AbbVie's Dividend Yield Safe?
With biosimilar competition ramping up, the drugmaker's free cash flows are poised to shrink this year. 
Via The Motley Fool
3 Dividend Stocks That Still Make Sense in 2023
Investors are still faced with an uncertain market which is favorable for these three dividend stocks regardless of what happens in the economy 
Via MarketBeat
Topics Economy
Exposures Economy
3 Dividend Growth Stocks to Buy and Hold
Where these dividends are going is even more important than where they've been. 
Via The Motley Fool
7 Spectacular High-Yield Dividend Stocks to Buy in July
These dividend yields could be hotter for investors than the temperatures this month. 
Via The Motley Fool
10 Best Stocks to Buy Now, Stock Market News, and Investing Q&A
Where is the stock market headed and which are the best stocks to buy now in an uncertain market? 
Via The Motley Fool
7 Stocks That AI Says Will Make You a Millionaire by 2025
These seven millionaire-maker stocks are changing hands at deeply undervalued levels. As their growth re-accelerates, so will your portfolio. 
Via InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For July 14, 2023
Via Benzinga
3 Biotech Stocks to Sell Before They Damage Your Portfolio
With the Street generally bearish towards the biotech sector, investors need to identify biotech stocks to avoid at this point. 
Via InvestorPlace
3 Biotech Stocks That AI is Loving in July
As AI becomes a more entrenched aspect of society, investors can lean on these AI recommended biotech stocks with predicted high potential. 
Via InvestorPlace
3 No-Brainer Stocks You Can Buy Right Now
Going with these stocks is an easy decision. 
Via The Motley Fool
The 3 Best Dividend Stocks to Buy in July
Not all stocks pay dividends, and not all dividend payments are equal. Some dividends are more generous than others, and investors seeking to maximize their income need to pay attention to the yield... 
Via InvestorPlace
2 Struggling Dividend Growth Stocks That Could Make You Richer
Let's look beyond these drugmakers' ongoing issues. 
Via The Motley Fool
Why Dividend Stocks Should Be a Key Part of Your Retirement Plan
You can collect the dividend income while keeping your original investment intact. 
Via The Motley Fool
The 7 Best Long-Term Stocks to Buy in July
Although it might not be the most exciting approach, the best long-term stocks in July offer a greater chance of upside success. 
Via InvestorPlace
Got $5,000? These Are 3 of the Best Stocks to Buy in July
There's something here for dividend, value, and growth investors. 
Via The Motley Fool
< Previous 1 2
...
23 24 25 26 27 28 29 30 31
...
69 70 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback